The impact of complete versus partial preservation of the sub-valvular apparatus on left ventricular function in mitral valve replacement.


Journal

Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809

Informations de publication

Date de publication:
Dec 2022
Historique:
revised: 07 09 2022
received: 19 06 2022
accepted: 02 10 2022
pubmed: 27 10 2022
medline: 6 1 2023
entrez: 26 10 2022
Statut: ppublish

Résumé

In mitral valve replacement (MVR), sudden increases in afterload and disruption of the annular-chordal-papillary-left-ventricular wall causes left ventricular (LV) dysfunction in the early postoperative period. Preservation of the posterior mitral leaflet apparatus (MVR-P) has a favorable outcome on LV function. However, there is paucity of data on the impact of complete preservation of the sub-valvular apparatus (MVR-C). We investigated the impact of MVR-P and MVR-C on baseline and 3-months postoperative LV ejection fraction (EF) and global longitudinal strain (GLS). We retrospectively analyzed a cohort of 29 MVR-P and 19 MVR-C patients with complete echocardiography data at our unit, who were operated between 2008 and 2017. Between-group changes in LVEF and GLS were compared using independent sample T-test. Median age was 59 years (IQR 50-69 years). Baseline LVEF was 58% (51%- 60%). Baseline GLS was -18.4 (-21.2 to -15.5). There were no significant between-group differences between all baseline demographics and echocardiographic markers. There was significantly higher absolute postoperative LVEF in MVR-C patients (p = 0.029). There was also significant worsening in LVEF (p = 0.0121) and GLS (p < 0.0001) after MVR-P and not MVR-C, suggesting no reduction in LV function post-MVR-C but a reduction post-MVR-P. There was significantly less postoperative worsening of GLS per patient in MVR-C group as compared to the MVR-P group (p = 0.023), indicating better preservation of LV function. There was also a smaller decline in LVEF per patient in the MVR-C as compared to the MVR-P group, although not statistically significant (p = 0.23). MVR with complete preservation of the sub-valvular apparatus shows a favorable impact on the longitudinal function of the heart at 3 months. Further studies with larger patient numbers are indicated to investigate the long-term results of this surgical approach.

Identifiants

pubmed: 36284463
doi: 10.1111/jocs.17049
pmc: PMC10092726
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4598-4605

Informations de copyright

© 2022 The Authors. Journal of Cardiac Surgery published by Wiley Periodicals LLC.

Références

Heart. 2003 Nov;89(11):1316-21
pubmed: 14594888
Ann Thorac Surg. 1994 Oct;58(4):931-43; discussion 943-4
pubmed: 7944814
Ann Thorac Surg. 1995 Apr;59(4):1027-9
pubmed: 7695385
J Card Surg. 2004 Nov-Dec;19(6):528-34
pubmed: 15548186
J Cardiothorac Surg. 2019 Jun 7;14(1):102
pubmed: 31174558
J Thorac Cardiovasc Surg. 1988 Aug;96(2):253-60
pubmed: 3260979
J Card Surg. 2022 Dec;37(12):4598-4605
pubmed: 36284463
Eur Heart J. 1991 Jul;12 Suppl B:48-51
pubmed: 1936024
Ann Thorac Surg. 1987 May;43(5):561-3
pubmed: 3579417
Eur J Cardiothorac Surg. 2011 Jun;39(6):866-74; discussion 874
pubmed: 21167733
JACC Cardiovasc Imaging. 2017 May;10(5):518-522
pubmed: 27743951
Eur J Cardiothorac Surg. 2013 Nov;44(5):905-12
pubmed: 23428575
J Thorac Cardiovasc Surg. 1964 Apr;47:532-43
pubmed: 14180754
Ann Thorac Surg. 2015 Oct;100(4):1347-52
pubmed: 26163972
Asian Cardiovasc Thorac Ann. 2005 Sep;13(3):233-7
pubmed: 16112995
Tex Heart Inst J. 2014 Apr 01;41(2):165-9
pubmed: 24808776
Cardiovasc Ultrasound. 2019 Sep 2;17(1):18
pubmed: 31477137
J Am Coll Cardiol. 2000 Oct;36(4):1152-8
pubmed: 11028464
J Thorac Cardiovasc Surg. 2002 Apr;123(4):707-14
pubmed: 11986599
Echo Res Pract. 2019 Jun 13;6(3):R87-R98
pubmed: 31289687
Ann Thorac Surg. 2005 Jun;79(6):1926-33
pubmed: 15919286
Heart. 2014 Nov;100(21):1673-80
pubmed: 24860005
Eur J Cardiothorac Surg. 2008 Mar;33(3):391-401
pubmed: 18249001
Cardiovasc Surg. 1998 Apr;6(2):133-8
pubmed: 9610825

Auteurs

Clarissa Ng Yin Ling (C)

Department of Cardiothoracic Surgery, King's College Hospital, London, UK.

Fulya Avci Demir (F)

Department of Cardiology, King's College Hospital, London, UK.

David Bleetman (D)

Department of Cardiothoracic Surgery, King's College Hospital, London, UK.

Mehdi Eskandari (M)

Department of Cardiology, King's College Hospital, London, UK.

Habib Khan (H)

Department of Cardiothoracic Surgery, King's College Hospital, London, UK.

Max Baghai (M)

Department of Cardiothoracic Surgery, King's College Hospital, London, UK.

Ranjit Deshpande (R)

Department of Cardiothoracic Surgery, King's College Hospital, London, UK.

Mark J Monaghan (MJ)

Department of Cardiology, King's College Hospital, London, UK.

Olaf Wendler (O)

Department of Cardiothoracic Surgery, King's College Hospital, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH